Seroprevalence of SARS-CoV-2 infection in the Colombo Municipality region, Sri Lanka. Preprint
GHDx Entry last modified on: Mar 14, 2022
Data by Data Type
SARS-CoV-2 antibodies among people with cystic fibrosis prior to the vaccination campaign: A seroprevalence study in two specialized centres in Northern Italy
GHDx Entry last modified on: Jan 31, 2024
Second round statewide survey for estimation of the burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population of Karnataka, India. Preprint
GHDx Entry last modified on: May 12, 2022
Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study
GHDx Entry last modified on: Apr 10, 2023
Susceptibility and Virulence of Enterobacteriaceae Isolated from Urinary Tract Infections in Benin
GHDx Entry last modified on: Sep 17, 2024
Suicidal behaviours among Ugandan university students: a cross-sectional study
GHDx Entry last modified on: Mar 22, 2024
SARS-CoV-2 seroprevalence in Chattogram, Bangladesh before a National Lockdown, March-April 2021. Preprint
GHDx Entry last modified on: Mar 14, 2022
Stillbirths among Pregnant Women Admitted to Department of Obstetrics in a Tertiary Care Centre: A Descriptive Cross-sectional Study
GHDx Entry last modified on: Mar 22, 2024
SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey. Preprint
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 seroprevalence in Kaduna State, Nigeria during October/November 2021, following three waves of infection and immediately prior to detection of the Omicron variant
GHDx Entry last modified on: Jan 31, 2024
School-based online survey on chronic headache, migraine, and medication-overuse headache prevalence among children and adolescents in Japanese one city - Itoigawa Benizuwaigani study
GHDx Entry last modified on: Mar 22, 2024
Socioeconomic position and SARS-CoV-2 infections: seroepidemiological findings from a German nationwide dynamic cohort. Preprint
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 Herd Immunity of the Kyrgyz Population in 2021. Preprint
GHDx Entry last modified on: Apr 8, 2022
Spatial analysis of malaria in Kotabaru, South Kalimantan, Indonesia: an evaluation to guide elimination strategies
GHDx Entry last modified on: Apr 10, 2023
Secular trends in the prevalence of diabetes and prediabetes among the rural population of South India
GHDx Entry last modified on: Dec 12, 2023
Seroprevalence of anti-SARS-CoV-2 antibodies six months into the vaccination campaign in Geneva, Switzerland. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of Antibodies Specific to Receptor Binding Domain of SARS-CoV-2 and Vaccination Coverage Among Adults in Los Angeles County, April 2021: The LA Pandemic Surveillance Cohort Study
GHDx Entry last modified on: Jan 31, 2024
SARS-CoV-2 Seroprevalence in Western Romania, March to June 2021
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of COVID-19 infection among vaccine naïve population after the second surge (June 2020) in a rural district of South India: A community-based cross-sectional study
GHDx Entry last modified on: Jan 31, 2024
Systemic inflammation, enteropathogenic E. Coli, and micronutrient insufficiencies in the first trimester as possible predictors of preterm birth in rural Bangladesh: a prospective study
GHDx Entry last modified on: Oct 23, 2024
Seroprevalence of Anti-SARS-CoV-2 Antibodies in Benadir Region, Somalia
GHDx Entry last modified on: Jan 31, 2024
Serological prevalence of SARS-CoV-2 antibody among children and young age (between age 2-17 years) group in India: An interim result from a large multi-centric population-based seroepidemiological study. Preprint
GHDx Entry last modified on: Apr 8, 2022
Seroprevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Campeche Mexico
GHDx Entry last modified on: Apr 10, 2023
Seroprevalence of antibodies against SARS-CoV-2 virus in the adult Norwegian population, winter 2020/2021: pre-vaccination period. Preprint
GHDx Entry last modified on: May 12, 2022
SARS-CoV-2 infection and transmission in school settings during the second wave in Berlin, Germany: a cross-sectional study. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence in Tamil Nadu through India’s two COVID waves: Evidence on antibody decline following infection and vaccination. Preprint
GHDx Entry last modified on: May 12, 2022
Seroprevalence of SARS-CoV-2 Infection Among Occupational Groups from Bucaramanga Metropolitan Area, Colombia. Preprint
GHDx Entry last modified on: Oct 5, 2022
SARS-CoV-2 infections in kindergartens and associated households at the start of the second wave in Berlin, Germany – a cross sectional study. Preprint
GHDx Entry last modified on: Mar 14, 2022
Sero-pravelence of SARS CoV-2 IgM and IgG Antibodies Amongst Blood Donors in Nigeria. Preprint
Epi surveillance
Serial SARS-CoV-2 Seropravelence Studies in Delhi July-August 2020: Indications of Pre-existing Cross-reactive Antibodies and Implications for Disease Progression
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 Seroprevalence in 12 Cities of India from July-December 2020. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Loreto, Peru. Preprint
GHDx Entry last modified on: Jun 18, 2021
Seroprevalence of anti-SARS-CoV-2 IgG at the epidemic peak in French Guiana. Preprint
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 seroprevalence in Germany - a population based sequential study in five regions. Preprint
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 seroprevalence and characteristics of post-infection immunity in a general population cohort study in Catalonia, Spain. Preprint
GHDx Entry last modified on: May 12, 2022
SARS-CoV-2 antibody prevalence and symptoms in a local Austrian population. Preprint
GHDx Entry last modified on: Mar 14, 2022
Sero-prevalence of SARS-CoV-2 Antibody Among Adults in the General Population in Diredawa, Ethiopia. Preprint
GHDx Entry last modified on: Sep 13, 2022
SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic
GHDx Entry last modified on: Dec 11, 2023
SARS CoV-2 Serosurvey in Addis Ababa, Ethiopia. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 antibodies in an entirely PCR-sampled and quarantined community after a COVID-19 outbreak - the CoNAN study. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 in the West Bank region of Palestine: a cross-sectional seroepidemiological study
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 IgM and IgG antibodies in an asymptomatic population in Sergipe, Brazil
GHDx Entry last modified on: Jun 17, 2021
Seroprevalence of Specific Antibodies against SARS-CoV-2 from Hotspot Communities in the Dominican Republic
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies: Results from a population-based study in Bonn, Germany. Preprint
GHDx Entry last modified on: Mar 14, 2022
Sero-prevalence of anti-SARS-CoV-2 Antibodies in Addis Ababa, Ethiopia. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 Seroprevalence During the First and Second Pandemic Waves in Canada. Preprint.
GHDx Entry last modified on: May 12, 2022
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of COVID-19 virus infection in Guilan province, Iran. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2-Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020
GHDx Entry last modified on: Mar 14, 2022
Pages
Subscribe
